JAMA Oncology published a pilot randomized controlled trial out of Memorial Sloan Kettering's Integrative Medicine Service (major props to MSK for their work with cancer AND ACUPUNCTURE). The NOCTURNAL trial. Sixty prostate cancer survivors, mean age seventy two, randomized two to one to either ten weekly acupuncture treatments or a usual care waitlist control. Every participant came in with at least two nocturia episodes per night for the past month. Outcomes were measured with the International Prostate Symptom Score, the validated instrument for this work.